-
Smegglutide sells for over 20 billion US dollars and Novo Nordisk continues to expand production
On January 31st, Novo Nordisk released its 2023 financial report, with a total annual revenue of approximately DKK 232.261 billion (approximately USD 33.771 billion), a year-on-year increase of 31%; ... -
Is the price of generic drugs only one tenth? How to price the slimming drug Smegglutide domestically
With the approval of the world's first GLP-1RA weekly formulation (trade name: Novo Nordisk) developed and produced by Novo Nordisk for long-term weight management in China, pricing and commercializa ... -
Oral "weight loss medication" further advances Novo Nordisk oral semaglutide weight loss phase III research success
Reporter Chen Xing On August 7th, Novo Nordisk announced its H1 2024 results that the Phase III OASIS 4 study on weight loss with oral semaglutide Rybelsus (25mg) has been successfully completed. Ora ... -
Lilly weight loss pills are crazily chasing after semaglutide
On August 8th, Eli Lilly released its second quarter financial report, achieving global revenue of $11.3028 billion, a year-on-year increase of 36%; The total revenue for the first half of the year w ...